Search - tctmd.com

Displaying 1 - 5 of 5

Sort: Relevancy | Date

Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months

News Conference News TCT 2017

MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months

TCT Daily Staff

November 06, 2017

Live From Denver: TCT 2017, Day Three

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Three

November 01, 2017

First Report of the Six Month Outcomes of the MAVERIC Trial of Transcatheter Annular Reduction Therapy (TART) With the ARTO™ System for Functional Mitral Regurgitation (FMR)

Presentation TCT 2017

First Report of the Six Month Outcomes of the MAVERIC Trial of Transcatheter Annular Reduction Therapy (TART) With the ARTO System for Functional Mitral Regurgitation (FMR)

Presenter: Daniel Burkhoff, Samir R. Kapadia, Stephen G. Worthley

November 01, 2017

MVRx ARTO System (Septal Sinus Shortening) and the MAVERIC Trial

Presentation TCT 2015

MVRx ARTO System (Septal Sinus Shortening) and the MAVERIC Trial

Presenter: Steven L. Goldberg, Joachim Schofer, Andrejs Erglis

October 14, 2015

Initial Results of the Mitral Valve Repair Clinical Trial (MAVERIC Trial) Utilizing Percutaneous Septal Sinus Shortening (The MVRx System) for the Treatment of Functional Mitral Regurgitation

Presentation TCT 2014

Initial Results of the Mitral Valve Repair Clinical Trial (MAVERIC Trial) Utilizing Percutaneous Septal Sinus Shortening (The MVRx System) for the Treatment of Functional Mitral Regurgitation

Presenter: Francesco Maisano, Gregg W. Stone, Brian K. Whisenant, Andrejs Erglis

September 14, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.